Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Extraordinary claims require extraordinary evidence

2 references·13 citing·32 second hop

FromToDepth

this work references cited by second hop

References

2003The price of innovation: new estimates of drug development costs4,264 cited
1991Cost of innovation in the pharmaceutical industry763 cited

Cited by

2009Spending on new drug development1277 cited
2011US biopharmaceutical finance and the sustainability of the biotech business model233 cited
2011US Biopharmaceutical Finance and the Sustainability of the Biotech Business Model199 cited
2015The Cost of Drug Development121 cited
2008Pharmaceutical pricing policies in a global market107 cited
2008Pharmaceutical Pricing Policies in a Global Market72 cited
2005Spending on New Drug Development66 cited
2008Enabling TRIPs: The pharma–biotech–university patent coalition27 cited
2017The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector26 cited
2016Do Extraordinary Claims Require Extraordinary Evidence?25 cited
2010Patents and Pharmaceutical R&D: Consolidating Private-Public Partnership Approach to Global Public Health Crises20 cited
2016Intellectual Property & Global Policy13 cited
2017Addressing Reproducibility: Peer Review, Impact Factors, Checklists, Guidelines, and Reproducibility Initiatives

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

11 cited